Hyderabad, 02nd April 2025: Rx Propellant, India’s premier life sciences infrastructure platform backed by Actis, unveils 1GV, a cutting-edge 136,000 sq. ft. research and innovation campus built over 1.8 acres in Genome Valley, Hyderabad. This launch marks another milestone in Rx Propellant’s unwavering commitment to advancing India’s life sciences ecosystem and shaping its future. The […]
The post Rx Propellant Secures Growth with 1GV Launch in Genome Valley first appeared on Business News Week.
Comments are closed